OR WAIT null SECS
- Advertise
- About Us
- Editorial Board
- Contact Us
- Job Board
- Terms and Conditions
- Privacy
- Do Not Sell My Personal Information
© 2021 MJH Life Sciences™ and Infection Control Today. All rights reserved.
BioNeutral and Barnabas Health to Collaborate for Surgical Instrument Sterilization
BioNeutral Group, Inc. and Barnabas Health in West Orange, N.J., jointly announce a collaborative research and revenue sharing agreement. The parties will develop protocols to trial Ygiene 206, a detergent cleaner, 90-second disinfectant and 20-minute sterilant. In addition, they will test new formulations designed for rapid cleaning and sterilization of surgical instruments, scopes, fabric and skin at Barnabas Health facilities.
Barnabas Health is the largest nonprofit integrated healthcare delivery system in New Jersey and one of the largest in the nation, treating more than two 2 million patients annually. The system includes 50 facilities with six acute-care hospitals, two children's hospitals, a behavioral health center, ambulatory care centers, surgery centers, breast and imaging centers, the state's largest behavioral health network, and comprehensive home care and hospice programs.
"We are excited to have access to world-first technology," says Barry H. Ostrowsky, president and CEO of Barnabas Health. "We see our role as being at the forefront of excellent care, utilizing the best tools available. Under the terms of the agreement, we will help develop new applications for the technology and Barnabas Health will have the first right to publish the data being generated. Barnabas Health will share in the commercial success produced by this collaboration."
"It is very important for technology-based companies like Bioneutral to engage with major healthcare providers to develop the best protocols for use and the data to demonstrate efficacy for the healthcare sector," says Andy Kielbania, CEO of Bioneutral Group, Inc. "Technology is a key factor in creating efficiencies which will drive down cost, mitigate risks and protect patients, staff and the public."
Nancy Chobin, RN, CSPDM, has been chosen as the principal researcher/investigator and, in conjunction with the Infection Prevention Department at Saint Barnabas Medical Center, will approve the protocols for testing and supervise the test process and the collection of data. Chobin is nationally recognized as a leader in the field of infection prevention and sterilization.
